TEL AVIV, Israel, Feb. 10, 2026 /PRNewswire/ -- Protai, www.protai.bio, an AI drug discovery startup, announced its participation in a series of major scientific conferences this spring, where it will present significant advances in its AIMS™ proteomics-aware-AI drug discovery platform...
Hence then, the article about protai to showcase groundbreaking aims drug discovery platform and best in class prt001 kat6a degrader results at spring 2026 global conferences was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Protai to showcase groundbreaking AIMS™ drug discovery platform and best-in-class PRT001 KAT6A degrader results at spring 2026 global conferences. )
Also on site :
- Say Goodbye to the Undersea Cable That Made the Global Internet Possible
- Commotion Launches Enterprise AI Operating System Powered by NVIDIA Nemotron™ Open Models to Scale Productivity For Digital Workforces
- RemotePass führt SpendCards ein, um das Chaos bei der Kostenerstattung für globale Teams zu beseitigen